Interferon-gamma release assays for the diagnosis of active tuberculosis in HIV-infected patients: A systematic review and meta-analysis

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Chen, Jun ^a   Zhang, Renfang ^a   Wang, Jiangrong ^a   Liu, Li ^a   Zheng, Yufang ^a   Shen, Yinzhong ^a   Qi, Tangkai ^a   Lu, Hongzhou ^a,b,c  

^a SHANGHAI PUBLIC HEALTH CLINICAL CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON;

ADULT; ARTICLE; AUSTRIA; BACTERIUM CULTURE; BULGARIA; CD4+ T LYMPHOCYTE; CHINA; CONTROLLED STUDY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ENZYME LINKED IMMUNOSPOT ASSAY; ETHIOPIA; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INDIA; INTERFERON GAMMA RELEASE ASSAY; ITALY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPAIN; SYSTEMATIC REVIEW; TANZANIA; TUBERCULOSIS; UGANDA; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOASSAY; IMMUNOLOGY; META ANALYSIS (TOPIC); MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; REVIEW; SECRETION;

MYCOBACTERIUM TUBERCULOSIS;

HIV; HIV INFECTIONS; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; META-ANALYSIS AS TOPIC; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 80055111820     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026827     Document Type: Article

References (35)

1. World Health Organization (2010) Global Tuberculosis Control 2010. Available: http://www.who.int/entity/tb/publications/global_report/2010/gtbr10_main.pdf. Accessed 15 July 2011.
2. Getahun H, Harrington M, O'Brien R, Nunn P, (2007) Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 369: 2042-2049.
3. Schutz C, Meintjes G, Almajid F, Wilkinson RJ, Pozniak A, (2010) Clinical management of tuberculosis and HIV-1 co-infection. Eur Respir J 36: 1460-1481.
4. Sester M, Giehl C, McNerney R, Kampmann B, Walzl G, et al. (2010) Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection. Eur Respir J 36: 1242-1247.
5. Garcia GF, Moura AS, Ferreira CS, Rocha MO, (2007) Clinical and radiographic features of HIV-related pulmonary tuberculosis according to the level of immunosuppression. Rev Soc Bras Med Trop 40: 622-626.
6. Burman WJ, Jones BE, (2003) Clinical and radiographic features of HIV-related tuberculosis. Semin Respir Infect 18: 263-271.
7. Menzies D, Pai M, Comstock G, (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-354.
8. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, et al. (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 58: 1-207; quiz CE201-204.
9. Pozniak AL, Coyne KM, Miller RF, Lipman MCI, Freedman AR, et al. (2010) British HIV Association guidelines for the treatment of TB/HIV coinfection 2010. Available: http://www.bhiva.org/documents/Guidelines/TB/110204Cons-TB_Coinfection_guideline.pdf. Accessed 15 July 2011.
10. Aichelburg MC, Rieger A, Breitenecker F, Pfistershammer K, Tittes J, et al. (2009) Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 48: 954-962.
11. Tan CK, Hung CC, Lai CC, Liao CH, Chou CH, et al. (2010) Diagnosis of active tuberculosis by enzyme-linked immunospot assay for interferon-gamma in HIV-infected patients. J Acquir Immune Defic Syndr 53: 546-547.
12. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, et al. (2011) Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 37: 100-111.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151: 264-269 W264.
14. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J, (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3: 25.
15. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, et al. (2006) Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 6: 9.
16. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A, (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6: 31.
17. Aabye MG, Ravn P, PrayGod G, Jeremiah K, Mugomela A, et al. (2009) The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 4: e4220.
18. Aabye MG, Ruhwald M, Praygod G, Jeremiah K, Faurholt-Jepsen M, et al. (2010) Potential of interferon-gamma-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients. Eur Respir J 36: 1488-1490.
19. Garcia-Gasalla M, Fernandez-Baca V, Mir-Viladrich I, Cifuentes-Luna C, Campins-Rosello A, et al. (2010) [Quantiferon-TB Gold In-Tube test in the diagnosis of pulmonary and extra-pulmonary tuberculosis]. Enferm Infecc Microbiol Clin 28: 685-689.
20. Syed Ahamed Kabeer B, Sikhamani R, Swaminathan S, Perumal V, Paramasivam P, et al. (2009) Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS One 4: e5718.
21. Kabeer BS, Sikhamani R, Raja A, (2010) Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 24: 323-325.
22. Legesse M, Ameni G, Mamo G, Medhin G, Bjune G, et al. (2010) Performance of QuantiFERON-TB Gold In-Tube (QFTGIT) for the diagnosis of Mycobacterium tuberculosis (Mtb) infection in Afar Pastoralists, Ethiopia. BMC Infect Dis 10: 354.
23. Ling DI, Pai M, Davids V, Brunet L, Lenders L, et al. (2011) Are interferon-{gamma} release assays useful for active tuberculosis in a high-burden setting? Eur Respir J.
24. Rangaka MX, Gideon HP, Wilkinson KA, Pai M, Mwansa-Kambafilwe J, et al. (2011) No discriminatory value of interferon release added to smear negative HIV-tuberculosis algorithms. Eur Respir J.
25. Sauzullo I, Mengoni F, Scrivo R, Valesini G, Potenza C, et al. (2010) Evaluation of QuantiFERON-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. Int J Tuberc Lung Dis 14: 834-840.
26. Veldsman C, Kock MM, Rossouw T, Nieuwoudt M, Maeurer M, et al. (2009) QuantiFERON-TB GOLD ELISA assay for the detection of Mycobacterium tuberculosis-specific antigens in blood specimens of HIV-positive patients in a high-burden country. FEMS Immunol Med Microbiol 57: 269-273.
27. Cattamanchi A, Ssewenyana I, Davis JL, Huang L, Worodria W, et al. (2010) Role of interferon-gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection. BMC Infect Dis 10: 75.
28. Oni T, Patel J, Gideon HP, Seldon R, Wood K, et al. (2010) Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts. Eur Respir J 36: 594-600.
29. Vincenti D, Carrara S, Butera O, Bizzoni F, Casetti R, et al. (2007) Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol 150: 91-98.
30. Markova R, Todorova Y, Drenska R, Elenkov I, Yankova M, et al. (2009) Usefulness of interferon gamma release assays in the diagnosis of tuberculosis infection in HIV infected patients in Bulgaria. Biotechnol Biotechnol 23: 1103-1108.
31. Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, et al. (2011) Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 56: 230-238.
32. Hoffmann M, Ravn P, (2010) The Use of Interferon-gamma Release Assays in HIV-positive Individuals. Eur Inf Dis 4: 23-29.
33. Diel R, Loddenkemper R, Nienhaus A, (2010) Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 137: 952-968.
34. Raby E, Moyo M, Devendra A, Banda J, De Haas P, et al. (2008) The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis. PLoS One 3: e2489.
35. Tsiouris SJ, Coetzee D, Toro PL, Austin J, Stein Z, et al. (2006) Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol 44: 2844-2850.